The MAPK/ERK signaling pathway is another crucial target for inhibitors. This pathway is involved in managing cell survival, differentiation, and growth. Inhibitors targeting MAPK/ERK are employed in cancer cells treatments to stop unrestrained cell expansion and tumor growth. In a similar way, JAK/STAT signaling inhibitors regulate immune reaction